MEMORY PHARMACEUTICALS CORP (MEMY) is a publicly traded company in the Unknown sector. Across all available filings, 22 corporate insiders have executed 94 transactions totaling $12.6M, demonstrating a bullish sentiment with $1.2M in net insider flow. The most recent transaction on Jan 5, 2009 involved a transaction of 2,075 shares valued at $1.3K.
No significant insider buying has been recorded for MEMY in the recent period.
No significant insider selling has been recorded for MEMY in the recent period.
Based on recent SEC filings, insider sentiment for MEMY is bullish with an Insider Alignment Score of 55/100 and a net flow of $1.2M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at MEMORY PHARMACEUTICALS CORP (MEMY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 22 insiders are actively trading MEMY stock, having executed 94 transactions in the past 90 days. The most active insider is Bioventures IV Qp Lp Mpm (Executive), who has made 3 transactions totaling $11.2M.
Get notified when executives and directors at MEMY file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 5, 2009 | R. Sulat James | Executive | Disposition | 2,075 | $0.61 | $1.3K | |
| Jan 5, 2009 | Lalani Jzaneen | Executive | Disposition | 2,075 | $0.61 | $1.3K | |
| Jan 5, 2009 | R. Murray Stephen | Executive | Disposition | 1,947 | $0.61 | $1.2K | |
| Jan 5, 2009 | P. Smith Michael | Executive | Disposition | 2,075 | $0.61 | $1.3K | |
| Jan 5, 2009 | Kroin David | Executive | Tender | 2,609,978 | $0.61 | $1.6M | Large |
| Jan 5, 2009 | Kroin David | Executive | Tender | 1,346,349 | $0.61 | $821.3K | Large |
| Jan 5, 2009 | Kroin David | Executive | Tender | 809,581 | $0.61 | $493.8K | |
| Jan 5, 2009 | Kroin David | Executive | Tender | 2,223,319 | $0.61 | $1.4M | Large |
| Jan 5, 2009 | Kroin David | Executive | Tender | 1,146,890 | $0.61 | $699.6K | Large |
| Jan 5, 2009 | Kroin David | Executive | Tender | 689,643 | $0.61 | $420.7K | |
| Jan 1, 2009 | Gilbert Walter Phd | Executive | Tender | 119,298 | $0.61 | $72.8K | |
| Jan 1, 2009 | Gilbert Walter Phd | Executive | Tender | 66,666 | $0.61 | $40.7K | |
| Jan 1, 2009 | I. Kriebel Robert | Executive | Tender | 5,000 | $0.61 | $3.0K | |
| Jan 1, 2009 | E. Meyers Michael | Executive | Tender | 68,222 | $0.61 | $41.6K | |
| Jan 1, 2009 | R. Sulat James | Executive | Tender | 14,487 | $0.61 | $8.8K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Tender(U) | 25 | $26.7M | 51.3% |
Exercise (Options)(X) | 11 | $12.7M | 24.4% |
Purchase(P) | 10 | $6.9M | 13.3% |
Sale(S) | 39 | $5.7M | 10.9% |
Award(A) | 1 | $12.0K | 0.0% |
Disposition(D) | 4 | $5.0K | 0.0% |
Other(J) | 4 | $0 | 0.0% |
Insider activity at MEMORY PHARMACEUTICALS CORP shows mixed signals across all time. While $6.9M in purchases indicates some executive confidence,$5.7M in sales balances the picture, resulting in a modest net flow of $1.2M.22 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Bioventures IV Qp Lp Mpm, has transacted $11.2M during this period.